phase

An ongoing Phase I/II clinical trial is evaluating VX-880 as a treatment for type 1 diabetes (T1D). Image courtesy of Ahmet Misirligul/Shutterstock. Vertex Pharmaceuticals The company announced positive data from …

Fasting proinsulin, fasting C-peptide, and the corresponding proinsulin to C-peptide ratio (PI:C). A and B, observed PI:C (A) and PI:C predicted by the model (B). Trends were generated from repeated …

Oramed hopes the upcoming Phase 3 trial will be even more successful. Image credit: Getty Images / Karl Tapales. oramed pharmaceutical announced that it is considering restarting a Phase 3 …